Clinical Trials Browser

INDUSTRY × Mesothelioma, Malignant × Gefitinib × Clear all

NCT00787410 2012-06-06

An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma

Phase 2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma